Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOrchestra BioMed Holdings Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.48 | -$0.36 | -$0.43 |
| Q2 2026 | 4 | -$0.43 | -$0.31 | -$0.39 |
| Q3 2026 | 4 | -$0.43 | -$0.35 | -$0.40 |
| Q4 2026 | 2 | -$0.55 | -$0.34 | -$0.42 |
| Q1 2027 | 2 | -$0.48 | -$0.29 | -$0.36 |
| Q2 2027 | 1 | -$0.48 | -$0.29 | -$0.36 |
| Q3 2027 | 1 | -$0.46 | -$0.28 | -$0.35 |
| Q4 2027 | 2 | -$0.44 | -$0.27 | -$0.33 |
| Q1 2028 | 3 | -$0.41 | -$0.25 | -$0.31 |
| Q2 2028 | 2 | -$0.36 | -$0.22 | -$0.27 |
| Q3 2028 | 2 | -$0.35 | -$0.21 | -$0.26 |
| Q4 2028 | 3 | -$0.32 | -$0.19 | -$0.24 |
| Q1 2029 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2029 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2029 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2029 | 2 | $0.00 | $0.00 | $0.00 |
| Q1 2030 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2030 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2030 | 1 | $0.00 | $0.00 | $0.00 |
Orchestra BioMed Holdings Inc Earnings Date And Information
Orchestra BioMed Holdings Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.33 earnings per share for the quarter, topping analysts' consensus estimates of $-0.4 by $0.07. The company had revenue of 110.00 K for the quarter and had revenue of 33.48 M for the year. Orchestra BioMed Holdings Inc has generated $-1 earnings per share over the last year ($-1.38 diluted earnings per share) and currently has a price-to-earnings ratio of -2.87. Orchestra BioMed Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Orchestra BioMed Holdings Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.40 | -$0.54 | -0.14 | $918.71 K | $110.00 K |
| 03/12/2026 | Q4 2025 | -$0.38 | $0.16 | 0.54 | $931.00 K | $30.92 M |
| 11/10/2025 | Q3 2025 | -$0.38 | -$0.54 | -0.16 | $741.40 K | $861.00 K |
| 08/12/2025 | Q2 2025 | -$0.51 | -$0.50 | 0.01 | $778.83 K | $836.00 K |
| 05/12/2025 | Q1 2025 | N/A | -$0.49 | N/A | $522.33 K | $868.00 K |
| 03/31/2025 | Q4 2024 | N/A | -$0.42 | N/A | $838.67 K | $253.00 K |
| 11/12/2024 | Q3 2024 | -$0.44 | -$0.41 | 0.03 | $703.25 K | $987.00 K |
| 08/12/2024 | Q2 2024 | -$0.41 | -$0.45 | -0.04 | $850.00 K | $778.00 K |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.38 | 0.02 | $950.00 K | $620.00 K |
| 03/27/2024 | Q4 2023 | -$0.38 | -$0.36 | 0.02 | N/A | $262.00 K |
| 09/29/2023 | Q3 2023 | N/A | -$0.38 | N/A | N/A | $419.00 K |
| 06/30/2023 | Q2 2023 | N/A | -$0.35 | N/A | N/A | $915.00 K |
| 03/31/2023 | Q1 2023 | N/A | -$0.40 | N/A | N/A | $1.16 M |
| 12/30/2022 | Q4 2022 | N/A | -$0.42 | N/A | N/A | $1.10 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.44 | N/A | N/A | $1.16 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.25 | N/A | N/A | $401.00 K |
| 03/31/2022 | Q1 2022 | N/A | -$0.01 | N/A | N/A | $866.00 K |
| 12/31/2021 | Q4 2021 | N/A | -$0.39 | N/A | N/A | $-2,453,000 |
| 09/29/2021 | Q3 2021 | N/A | -$0.26 | N/A | N/A | $1.33 M |
| 06/29/2021 | Q2 2021 | N/A | -$0.30 | N/A | N/A | $-978,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Orchestra BioMed Holdings Inc Earnings: FAQ's
In the previous quarter, Orchestra BioMed Holdings Inc (:OBIO) reported $-0.33 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.4 by $0.07.
The conference call for Orchestra BioMed Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for Orchestra BioMed Holdings Inc's latest earnings report can be read online.
Orchestra BioMed Holdings Inc (:OBIO) has a recorded annual revenue of $33.48 M.
Orchestra BioMed Holdings Inc (:OBIO) has a recorded net income of $-52,701,000.Orchestra BioMed Holdings Inc has generated $-1.38 earnings per share over the last four quarters.
Orchestra BioMed Holdings Inc (:OBIO) has a price-to-earnings ratio of -2.87 and price/earnings-to-growth ratio is -0.22.